The company's financial leverage has increased significantly, with total debt rising from $1.7 million in 2023Q4 to $25.7 million by 2026Q1, signaling a reliance on external financing to fund operations.
| Total Current Assets | 80.67M | 71.78M | 57.63M | 47.44M | 58.76M | 104.18M | 4.02M | 17.42M |
| Cash & Short-Term Investments | 53.3M | 45M | 24.28M | 43.99M | 54.57M | 100.81M | 3.02M | 17.03M |
| Cash Only | 8.27M | 4.31M | 13.49M | 28.59M | 54.17M | 100.81M | 2.86M | 6.99M |
| Short-Term Investments | 45.03M | 40.69M | 10.79M | 15.4M | 400K | 0 | 168K | 10.04M |
| Accounts Receivable | 2.3M | 571K | 2.58M | 3.21M | 3.96M | 3.17M | 137K | 0 |
| Days Sales Outstanding | 346.71 | 203.13 | 1.23K | 798.28 | 410.56 | 514.47 | 150.62 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 25.07M | 26.21M | 30.7M | 163K | 144K | 125K | 844K | 346K |
| Total Non-Current Assets | 2.59M | 2.83M | 3.16M | 3.05M | 2.07M | 1.17M | 384K | 456K |
| Property, Plant & Equipment | 2.59M | 2.83M | 3.16M | 3.05M | 2.07M | 1.17M | 384K | 456K |
| Fixed Asset Turnover | 0.54x | 0.36x | 0.24x | 0.48x | 1.70x | 1.93x | 0.86x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 35.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 83.26M | 74.61M | 60.79M | 50.48M | 60.83M | 105.35M | 4.41M | 17.88M |
| Asset Turnover | 0.02x | 0.01x | 0.01x | 0.03x | 0.06x | 0.02x | 0.08x | - |
| Asset Growth % | 59.55% | 22.74% | 20.41% | -17.01% | -42.26% | 2291.51% | -75.36% | - |
| Total Current Liabilities | 33.37M | 32.55M | 36.41M | 6.21M | 10.43M | 15.47M | 5.27M | 6.36M |
| Accounts Payable | 352K | 774K | 624K | 1.15M | 1.24M | 2M | 1.21M | 2.27M |
| Days Payables Outstanding | 89.84 | 154.55 | 146.66 | 278.11 | 353.9 | 508.21 | 1.3K | 3.5K |
| Short-Term Debt | 23.83M | 25.44M | 30.61M | 0 | 0 | 4.92M | 1.88M | 1.99M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 351K | 726K | 0 | 0 |
| Other Current Liabilities | 6.9M | 2.63M | 3.28M | 2.92M | 2.86M | 3.1M | 281K | 206K |
| Current Ratio | 2.42x | 2.21x | 1.58x | 7.64x | 5.63x | 6.74x | 0.76x | 2.74x |
| Quick Ratio | 2.42x | 2.21x | 1.58x | 7.64x | 5.63x | 6.74x | 0.76x | 2.74x |
| Cash Conversion Cycle | 256.87 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.34M | 1.24M | 1.89M | 2.18M | 1.65M | 10.06M | 3.85M | 2.6M |
| Long-Term Debt | 0 | 1.23M | 0 | 0 | 0 | 0 | 2.69M | 2.25M |
| Capital Lease Obligations | 6.86M | 1.23M | 1.46M | 1.31M | 17K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2K | -1.22M | 428K | 875K | 1.63M | 10.06M | 1.16M | 351K |
| Total Liabilities | 34.71M | 33.79M | 38.29M | 8.39M | 12.08M | 25.52M | 9.12M | 8.96M |
| Total Debt | 25.67M | 27.9M | 32.62M | 1.74M | 381K | 4.92M | 4.57M | 4.24M |
| Net Debt | 17.4M | 23.59M | 19.13M | -26.84M | -53.79M | -95.89M | 1.71M | -2.75M |
| Debt / Equity | 0.53x | 0.68x | 1.45x | 0.04x | 0.01x | 0.06x | - | 0.48x |
| Debt / EBITDA | -0.56x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.38x | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -1.34x | -22.43x | -52.91x |
| Total Equity | 48.55M | 40.82M | 22.5M | 42.09M | 48.75M | 79.82M | -4.72M | 8.92M |
| Equity Growth % | 367.88% | 81.45% | -46.56% | -13.66% | -38.92% | 1792.24% | -152.88% | - |
| Book Value per Share | 0.40 | 0.37 | 0.28 | 0.58 | 0.71 | 1.32 | -0.08 | 0.97 |
| Total Shareholders' Equity | 48.55M | 40.82M | 22.5M | 42.09M | 48.75M | 79.82M | -4.72M | 8.92M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -308.8M | -298.13M | -252.96M | -203.64M | -160.14M | -119.65M | -61.55M | -45.93M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Critical liquidity and dilution
As reported in recent financial filings, Arbe's equity base has experienced significant volatility, declining from $42.1 million in 2023Q4 to $48.6 million in 2026Q1, while the persistent accumulation of a $308.8 million deficit in retained earnings signals a structural erosion of shareholder value over the observed period.
The trajectory of the balance sheet reflects a company struggling to bridge the gap between R&D-heavy development and commercial revenue. The consistent expansion of the accumulated deficit suggests that the business model has yet to achieve the scale necessary to offset its high fixed-cost base, leaving the equity position increasingly reliant on external capital injections.
Based on the company's reported figures, total debt has climbed from $1.7 million in 2023Q4 to $25.7 million by 2026Q1, indicating an increasing reliance on debt financing to sustain operations as the company navigates its pre-commercial phase and attempts to reach mass-market production milestones.
The shift toward higher debt levels, particularly when contrasted with the company's limited cash reserves, suggests a potential tightening of financial flexibility. Investors should monitor whether this debt is being utilized for strategic growth or merely as a stop-gap measure to fund ongoing operating losses, as the current D/E ratio of 0.53 warrants caution.
According to the most recent balance sheet data, cash and equivalents have plummeted to $4.3 million as of 2025Q4, a sharp contraction from the $28.6 million reported in 2023Q4, which highlights an urgent need for additional funding to maintain operations through the upcoming fiscal cycles.
The current ratio of 2.21, while appearing superficially healthy, masks the reality of a rapidly depleting cash position relative to the company's high quarterly burn rate. This liquidity profile suggests that the company may face significant pressure to secure non-dilutive or dilutive financing in the near term to avoid operational disruption.
As indicated by the financial statements, the absence of goodwill and intangible assets on the balance sheet suggests that the company's valuation is almost entirely detached from tangible book value, leaving shareholders highly exposed to the binary outcome of the firm's proprietary 4D imaging radar technology success.
The lack of tangible asset backing means that the company's market value is essentially a proxy for its intellectual property and future commercial potential. This structure makes the balance sheet particularly sensitive to any delays in design wins or technical setbacks, as there is little in the way of hard assets to provide a floor for the company's valuation.
Quick answers to the most common questions about buying ARBE stock.
As of 2025, Arbe Robotics Ltd. (ARBE) had total assets of $74.6M including $71.8M in current assets.
Arbe Robotics Ltd. (ARBE) carries total debt of $27.9M, offset by $45.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Arbe Robotics Ltd. (ARBE) has total shareholders' equity (book value) of $40.8M ($0.37 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Arbe Robotics Ltd. (ARBE) reported a current ratio of 2.21x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.